The tumor growth rate was significantly inhibited while the average tumor weight and volume markedly decreased following the treatment of FXYD3‐overexpressing HCCC‐9810 cells with AZD1480 (Figure 5L; Figure S4E, Supporting Information). The gene discussed is FXYD3; the disease is neoplasm.